MarketPulse

stock decline

396 articles
The Motley FoolThe Motley Fool··Josh Kohn-Lindquist

Major Investor Exits ZoomInfo as Stock Plunges 92% Since Peak

Calydon Capital sells $9.2M ZoomInfo stake amid 92% stock decline since 2021, signaling investor pessimism over stalled sales growth.
SPYAAPLGTMIVWstock declinefree cash flow
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Paysafe Stock Crashes 27.6% on Missed Revenue, Fraud Lawsuit Filed

Paysafe Limited faces securities fraud lawsuit after missing Q3 revenue by $5.8M, reporting $87.7M loss. Stock plummeted 27.6% on undisclosed risks.
PSFEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

NuScale Power Stock Plummets 12.4% Over $495M ENTRA1 Deal; Securities Fraud Lawsuit Filed

NuScale Power faces securities fraud lawsuit after disclosing $495M payment to inexperienced nuclear startup ENTRA1 Energy, triggering 12.4% stock decline.
SMRsecurities fraudclass action lawsuit
BenzingaBenzinga··Law Offices Of Howard G. Smith

Alight Stock Faces Securities Fraud Suit Over Misleading Growth Claims

Class action lawsuit filed against $ALIT alleging executives made false statements about growth and cost cuts while concealing sales execution failures.
ALITsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Travis Hoium

SoFi CEO Doubles Down With $17.32 Share Buy as Muddy Waters Alleges Profit Overstatement

SoFi CEO buys stock at $17.32 following Muddy Waters short report. Company reports record Q4 revenue and ninth consecutive quarter of GAAP profitability.
SOFIstock declineprofitability
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Boston Scientific Faces Class Action Over $BSC Stock Plunge, Missed Earnings

Boston Scientific faces class action lawsuit after 17% stock decline following $0.45 EPS miss versus $0.48-$0.52 guidance, amid alleged undisclosed Electrophysiology market share losses.
BSXclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Nektar Therapeutics Faces Class Action Over Failed Trial and Alleged Disclosure Failures

Nektar Therapeutics faces class action lawsuit over alleged failure to disclose enrollment protocol violations in failed Phase 2b REZOLVE-AA trial, triggering 8% stock decline.
NKTRclass action lawsuitstock decline
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Portnoy Law Firm Files Class Action Against Alight Over Misleading Growth Forecasts

Portnoy Law Firm launches class action lawsuit against Alight, Inc. for allegedly making false revenue statements. Stock plummeted 56% cumulatively across two separate crashes in 2025-2026.
ALITsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

Trip.com Faces Securities Lawsuit After Antitrust Investigation Triggers 17% Stock Plunge

Trip.com stock plummeted 17% after China's antitrust regulator launched investigation into alleged monopolistic practices, sparking class action lawsuit.
TCOMstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Claimsfiler

Trip.com Faces Class Action Over China Antitrust Probe; Stock Plunges 17%

Trip.com ($TCOM) plummeted 17% after China's market regulator launched antitrust investigation. Class action lawsuit targets investors with losses exceeding $100,000.
TCOMstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

Plug Power Faces Securities Fraud Class Action Over DOE Loan Misrepresentations

Plug Power faces securities fraud lawsuit alleging DOE loan overstatements. Class period: January-November 2025. Investors can seek lead plaintiff status by April 3, 2026.
PLUGsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Snowflake Faces Class Action Over Product Claims as Stock Plunges 18%

Snowflake faces class action lawsuit alleging false statements about product efficiency, with stock down 18% during June 2023-February 2024 period. Lead plaintiff applications due April 2026.
SNOWsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Kessler Topaz Meltzer & Check, Llp

SLNO Stock Plummets 26% on Safety Concerns: Class Action Lawsuit Filed Against Soleno Therapeutics

Soleno Therapeutics faces securities fraud lawsuit over alleged safety misstatements in DCCR clinical trial. Stock fell 26% following August short-seller report.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

Trip.com Faces Securities Fraud Lawsuit Over China Monopoly Probe Disclosure

Kirby McInerney LLP filed class action lawsuit against $TCOM for allegedly understating regulatory risks before January 2026 stock plunge.
TCOMsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Soleno Therapeutics Faces Class Action Over DCCR Safety Claims as Stock Plummets

Soleno Therapeutics faces class action lawsuit over DCCR safety concealment claims, with investors suffering significant losses following critical short-seller report and patient death disclosure.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Inovio Faces Securities Class Action Over Failed FDA Approval Strategy

Inovio Pharmaceuticals faces a securities class action over allegedly false statements regarding manufacturing capabilities and regulatory prospects for INO-3107, following FDA's December 29 accelerated approval rejection.
INOstock declinesecurities class action
BenzingaBenzinga··Law Offices Of Frank R. Cruz

Alight Faces Securities Fraud Probe After Consecutive Revenue Misses and Dividend Cut

Securities fraud investigation launched against $ALIT following 18.3% and 38.2% stock declines tied to missed revenue guidance and earnings shortfalls in 2025-2026.
ALITstock declinesecurities fraud investigation
BenzingaBenzinga··Badar Shaikh

Airlines Turbulent Ride: $AAL Plunges 17% Amid Iran Tensions While $DAL Holds Steady

American Airlines dropped 16.91% amid Iran tensions, while Delta fell just 1.32% and United declined 12.33%. Delta faces $400M in fuel costs; American projects 10%+ Q1 revenue growth despite earnings losses.
DALUALAALstock declinegeopolitical tensions
GlobeNewswire Inc.GlobeNewswire Inc.··Kahn Swick & Foti, Llc

Corcept Therapeutics Plummets 50% After FDA Rejects Lead Drug; Class Action Lawsuit Filed

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant. Stock crashed 50% following misleading investor claims about approval prospects.
CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Kahn Swick & Foti, Llc

BellRing Brands Hit With Securities Fraud Suit Over Undisclosed Inventory Woes

BellRing Brands faces securities fraud class action for failing to disclose inventory issues. Stock plummeted 52% after May and August 2025 negative announcements.
BRBRsecurities fraudclass action lawsuit